Nephron-sparing surgery: Minimally invasive techniques

Nephron-sparing surgery (NSS) was initially developed as a mechanism to preserve renal function in patients at risk of requiring dialysis in the face of total nephrectomy. Indications included tumors in patients with a solitary kidney, multifocal disease, or chronic renal insufficiency.

Related Videos

Maria Uloko, MD, on the need for better education on female sexual dysfunction

Maria Uloko, MD, discusses the lack of resident training on female sexual dysfunction

Alternative treatments and patient communication for genitourinary syndrome of menopause

Yahir A. Santiago-Lastra, MD, discusses barriers to vaginal estrogen access

Expert discusses genitourinary syndrome of menopause guidelines

Karyn S. Eilber, MD, shares her reaction to genitourinary syndrome of menopause guidelines

Urology CNP discusses sensitivity in communication, physical exam

Ekene Enemchukwu, MD, on the need for better education on GSM, vaginal estrogen

Urologist discusses drug cost savings, price transparency

Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM

Related Content

Advertisement

May 16th 2025

Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI

Melissa Kaufman, MD, PhD, FACS Hannah Clarke

The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.

June 2nd 2025

Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

Amy M. Pearlman, MD

April 5th 2025

Vaginal prolapse repair and sling surgery significantly reduce UUI

Christina M. Mezes, DO Catherine A. Matthews, MD

"The biggest message from this study is that 60% can expect resolution of UUI, simply by fixing the prolapse and placing a sling, which is not normally indicated for UUI," according to Christina M. Mezes, DO, and Catherine A. Matthews, MD.

April 29th 2025

Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025

Amy M. Pearlman, MD Rachel Rubin, MD

Rachel Rubin, MD, discusses advancements in sexual health education and guidelines at the AUA meeting.

March 28th 2025

FDA grants marketing authorization to at-home diagnostic test for STIs

Hannah Clarke

The test can deliver diagnostic results for chlamydia, gonorrhea, and trichomoniasis.

March 25th 2025

Expert discusses unique mechanism of action of UTI treatment gepotidacin

Ryan Haumschild, PharmD, MS, MBA, CPEL

"I think [gepotidacin] gives a different side effect profile available to the clinicians, and I think for patients as well, it provides a better, more durable option over time," says Ryan Haumschild, PharmD, MS, MBA, CPEL.

Related Content

Female Urology

Female Urology

Advertisement

May 16th 2025

Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI

Melissa Kaufman, MD, PhD, FACS Hannah Clarke

The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.

June 2nd 2025

Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

Amy M. Pearlman, MD

April 5th 2025

Vaginal prolapse repair and sling surgery significantly reduce UUI

Christina M. Mezes, DO Catherine A. Matthews, MD

"The biggest message from this study is that 60% can expect resolution of UUI, simply by fixing the prolapse and placing a sling, which is not normally indicated for UUI," according to Christina M. Mezes, DO, and Catherine A. Matthews, MD.

April 29th 2025

Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025

Amy M. Pearlman, MD Rachel Rubin, MD

Rachel Rubin, MD, discusses advancements in sexual health education and guidelines at the AUA meeting.

March 28th 2025

FDA grants marketing authorization to at-home diagnostic test for STIs

Hannah Clarke

The test can deliver diagnostic results for chlamydia, gonorrhea, and trichomoniasis.

March 25th 2025

Expert discusses unique mechanism of action of UTI treatment gepotidacin

Ryan Haumschild, PharmD, MS, MBA, CPEL

"I think [gepotidacin] gives a different side effect profile available to the clinicians, and I think for patients as well, it provides a better, more durable option over time," says Ryan Haumschild, PharmD, MS, MBA, CPEL.